Adial Pharmaceuticals Inc (NASDAQ: ADIL)
$1.0150
-0.0050 ( -1.46% ) 64.9K
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Market Data
Open
$1.0150
Previous close
$1.0200
Volume
64.9K
Market cap
$6.60M
Day range
$0.9950 - $1.0700
52 week range
$0.7650 - $4.1699
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Apr 26, 2024 |
| 424b3 | Other | 2 | Apr 23, 2024 |
| effect | Other | 1 | Apr 19, 2024 |
| 8-k | 8K-related | 16 | Apr 18, 2024 |
| 424b5 | Other | 4 | Apr 18, 2024 |
| corresp | Comment letters | 2 | Apr 17, 2024 |
| upload | Comment letters | 2 | Apr 17, 2024 |
| 8-k | 8K-related | 13 | Apr 16, 2024 |
| s-3 | Registration statements | 6 | Apr 12, 2024 |
| 10-k | Annual reports | 76 | Apr 01, 2024 |